Immutep Statistics
Total Valuation
Immutep has a market cap or net worth of $49.96 million. The enterprise value is -$19.20 million.
| Market Cap | 49.96M |
| Enterprise Value | -19.20M |
Important Dates
The next estimated earnings date is Wednesday, August 12, 2026, before market open.
| Earnings Date | Aug 12, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
Immutep has 1.47 billion shares outstanding. The number of shares has increased by 9.74% in one year.
| Current Share Class | n/a |
| Shares Outstanding | 1.47B |
| Shares Change (YoY) | +9.74% |
| Shares Change (QoQ) | +0.84% |
| Owned by Insiders (%) | 2.66% |
| Owned by Institutions (%) | 54.79% |
| Float | 1.43B |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 9.45 |
| Forward PS | 2.41 |
| PB Ratio | 0.76 |
| P/TBV Ratio | 0.81 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 2.97, with a Debt / Equity ratio of 0.01.
| Current Ratio | 2.97 |
| Quick Ratio | 2.91 |
| Debt / Equity | 0.01 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -2,395.55 |
Financial Efficiency
Return on equity (ROE) is -61.85% and return on invested capital (ROIC) is -38.57%.
| Return on Equity (ROE) | -61.85% |
| Return on Assets (ROA) | -32.10% |
| Return on Invested Capital (ROIC) | -38.57% |
| Return on Capital Employed (ROCE) | -93.48% |
| Weighted Average Cost of Capital (WACC) | 16.10% |
| Revenue Per Employee | $170,472 |
| Profits Per Employee | -$1.81M |
| Employee Count | 31 |
| Asset Turnover | 0.05 |
| Inventory Turnover | n/a |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -77.95% in the last 52 weeks. The beta is 2.20, so Immutep's price volatility has been higher than the market average.
| Beta (5Y) | 2.20 |
| 52-Week Price Change | -77.95% |
| 50-Day Moving Average | 0.40 |
| 200-Day Moving Average | 1.42 |
| Relative Strength Index (RSI) | 44.58 |
| Average Volume (20 Days) | 222,373 |
Short Selling Information
The latest short interest is 2.15 million, so 1.50% of the outstanding shares have been sold short.
| Short Interest | 2.15M |
| Short Previous Month | 3.90M |
| Short % of Shares Out | 1.50% |
| Short % of Float | n/a |
| Short Ratio (days to cover) | 5.31 |
Income Statement
In the last 12 months, Immutep had revenue of $5.28 million and -$55.97 million in losses. Loss per share was -$0.04.
| Revenue | 5.28M |
| Gross Profit | -49.88M |
| Operating Income | -56.44M |
| Pretax Income | -55.97M |
| Net Income | -55.97M |
| EBITDA | -62.47M |
| EBIT | -62.47M |
| Loss Per Share | -$0.04 |
Balance Sheet
The company has $66.12 million in cash and $806,834 in debt, with a net cash position of $65.31 million or $0.04 per share.
| Cash & Cash Equivalents | 66.12M |
| Total Debt | 806,834 |
| Net Cash | 65.31M |
| Net Cash Per Share | $0.04 |
| Equity (Book Value) | 65.97M |
| Book Value Per Share | 0.04 |
| Working Capital | 61.88M |
Cash Flow
In the last 12 months, operating cash flow was -$43.92 million and capital expenditures -$89,685, giving a free cash flow of -$44.01 million.
| Operating Cash Flow | -43.92M |
| Capital Expenditures | -89,685 |
| Depreciation & Amortization | 1.58M |
| Net Borrowing | -187,248 |
| Free Cash Flow | -44.01M |
| FCF Per Share | -$0.03 |
Margins
| Gross Margin | n/a |
| Operating Margin | -1,068.07% |
| Pretax Margin | -1,059.19% |
| Profit Margin | n/a |
| EBITDA Margin | -2,139.63% |
| EBIT Margin | -2,139.63% |
| FCF Margin | n/a |
Dividends & Yields
Immutep does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -9.74% |
| Shareholder Yield | -9.74% |
| Earnings Yield | -112.04% |
| FCF Yield | -88.08% |
Analyst Forecast
The average price target for Immutep is $1.50, which is 288.80% higher than the current price. The consensus rating is "Buy".
| Price Target | $1.50 |
| Price Target Difference | 288.80% |
| Analyst Consensus | Buy |
| Analyst Count | 3 |
| Revenue Growth Forecast (3Y) | -11.39% |
| EPS Growth Forecast (3Y) | n/a |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
The last stock split was on December 28, 2016. It was a reverse split with a ratio of 1:3.33.
| Last Split Date | Dec 28, 2016 |
| Split Type | Reverse |
| Split Ratio | 1:3.33 |
Scores
Immutep has an Altman Z-Score of -0.55 and a Piotroski F-Score of 2. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | -0.55 |
| Piotroski F-Score | 2 |